Adiponectin and resistin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

The objective of this paper is to assess if disease activity, systemic inflammation and metabolic syndrome are potential determinants of circulating adiponectin and resistin levels in ankylosing spondylitis (AS) patients undergoing TNF-α antagonist therapy. We investigated adiponectin and resistin s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and experimental rheumatology 2013-05, Vol.31 (3), p.365-371
Hauptverfasser:	Miranda-Filloy, José A, López-Mejias, Raquel, Genre, Fernanda, Carnero-López, Beatriz, Ochoa, Rodrigo, Diaz de Terán, Teresa, González-Juanatey, Carlos, Blanco, Ricardo, Llorca, Javier, González-Gay, Miguel A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adipokines - blood Adiponectin - blood Adult Aged Antibodies, Monoclonal - therapeutic use Antirheumatic Agents - therapeutic use Blood Sedimentation C-Reactive Protein - analysis Cardiovascular Diseases - blood Cardiovascular Diseases - complications Cohort Studies Female Humans Infliximab Insulin Resistance Male Middle Aged Resistin - blood Spondylitis, Ankylosing - blood Spondylitis, Ankylosing - complications Spondylitis, Ankylosing - drug therapy Tumor Necrosis Factor-alpha - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!